Pulmonary hemorrhage after cardiac resynchronization therapy device implantation - A systematic review

Am J Med Sci. 2022 Dec;364(6):796-802. doi: 10.1016/j.amjms.2022.06.018. Epub 2022 Jul 5.

Abstract

Cardiac implantable electronic devices are being increasingly used for a variety of cardiovascular diseases. We describe a rare case of massive hemoptysis after device implantation. The patient was managed conservatively with reversal of anticoagulation and inhaled tranexamic acid and had a successful recovery. A systematic review accompanies the case presentation. The modality and difficulty of access appear to play a significant role in precipitating bleeding, believed to be the result of direct injury to the pulmonary parenchyma and vasculature. The condition is often self-limiting; however, anticoagulation reversal, intubation, endobronchial intervention, and transarterial embolization may be indicated in more severe pulmonary hemorrhage.

Keywords: Anticoagulants; CIED; Hemoptysis; Pacemaker; Postoperative Complications.

Publication types

  • Systematic Review
  • Case Reports
  • Review

MeSH terms

  • Cardiac Resynchronization Therapy Devices
  • Defibrillators, Implantable* / adverse effects
  • Hemorrhage / etiology
  • Hemorrhage / therapy
  • Humans
  • Pacemaker, Artificial*
  • Tranexamic Acid*

Substances

  • Tranexamic Acid